Host serological response to Helicobacter pylori after successful eradication: Long-term follow-up in patients with cured and persistent infection

Alimentary Pharmacology and Therapeutics Symposium Series

Volumn 2, Issue 1, 2006, Pages 239-248

  Tanaka, J ^a   Ohkusa, T ^b   Yokoyama, T ^c   Matsuhisa, T ^d   Kawai, T ^e   Hashimoto, H ^f   Tomita, T ^a   Hori, K ^a   Nakajima, K ^a   Matsumoto, T ^a   Miwa, H ^a  

^a HYOGO COLLEGE OF MEDICINE   (Japan)

^b JUNTENDO UNIVERSITY   (Japan)

^c NATIONAL INSTITUTE OF PUBLIC HEALTH   (Japan)

^d NIPPON MEDICAL SCHOOL   (Japan)

^e TOKYO MEDICAL UNIVERSITY   (Japan)

^f JR Tokyo General Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY;

ADULT; ANTIBODY TITER; CONFERENCE PAPER; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; ERADICATION THERAPY; FEMALE; FOLLOW UP; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HOST; HUMAN; MAJOR CLINICAL STUDY; MALE; PERSISTENT INFECTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; ROC CURVE; SENSITIVITY AND SPECIFICITY; SEROLOGY;

EID: 34247846169     PISSN: 17466334     EISSN: 17466342     Source Type: Journal    
DOI: 10.1111/j.1746-6342.2006.00052.x     Document Type: Conference Paper

References (28)

1. Van der Hulst RW, Rauws EA, Köycü B, et al. Prevention of ulcer recurrence after eradication of Helicobacter pylori: a prospective long-term follow-up study. Gastroenterology 1997 113:1082 6.
2. Wotherspoon AC, Doglioni C, Diss TC, et al. Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori. Lancet 1993 342:575 7.
3. Uemura N, Okamoto S, Yamamoto S, et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 2001 345:784 9.
4. Cutler A, Schubert A, Schubert T, et al. Role of Helicobacter pylori serology in evaluating treatment success. Dig Dis Sci 1993 38:2262 6.
5. Lerang F, Haug JB, Moum B, et al. Accuracy of IgG serology and other tests in confirming Helicobacter pylori eradication. Scand J Gastroenterol 1998 33:710 5.
6. Kosunen TU, Seppala K, Sarna S, et al. Diagnostic value of decreasing IgG, IgA, and IgM antibody titers after eradication of Helicobacter pylori. Lancet 1992 339:893 5.
7. Hirschl AM, Brandstatter G, Dragosics B, et al. Kinetics of specific IgG antibodies for monitoring the effect of anti-Helicobacter pylori chemotherapy. J Infect Dis 1993 168:763 6.
8. Perez-Perez GI, Cutler AF, Blaser MJ. Value of serology as a noninvasive method for evaluating the efficacy of treatment of Helicobacter pylori infection. Clin Infect Dis 1997 25:147 51.
9. Fanti L, Ieri R, Mezzi G, et al. Long-term follow-up and serologic assessment after triple therapy with omeprazole or lansoprazole of Helicobacter-associated duodenal ulcer. J Clin Gastroenterol 2001 32:45 8.
10. Marchildon P, Balaban DH, Sue M, et al. Usefulness of serological IgG antibody determination for confirming eradication of Helicobacter pylori infection. Am J Gastroenterol 1999 94:2105 8.
11. Hirschl AM, Rotter ML. Serological tests for monitoring Helicobacter pylori eradication treatment. J Gastroenterol 1996 31 (Suppl. 9 33 6.
12. Fallone CA, Loo VG, Barkun AN. Utility of serology in determining Helicobacter pylori eradication after therapy. Can J Gastroenterol 1998 12:117 24.
13. Hedeker D, Gibbons RD. A random-effects ordinal regression model for multilevel analysis. Biometrics 1994 50:933 44.
14. Evans DJ Jr., Evans DG, Graham DY, et al. A sensitive and specific serologic test for detection of Campylobacter pylori infection. Gastroenterology 1989 96:1004 8.
15. Crabtree JE, Shallcross TM, Heatley RV, et al. Evaluation of a commercial ELISA for serodiagnosis of Helicobacter pylori infection. J Clin Pathol 1991 44:326 8.
16. Jensen AK, Anderson LP, Gaarslev K, Wachmann CH. Comparison of four-second generation kits for detection of IgG antibodies against Helicobacter pylori in adults. Zentralbl Bakteriol 1993 280:221 6.
17. Schembri MA, Lin S, Lambert JR. Comparison of commercial diagnosis tests for Helicobacter pylori antibodies. J Clin Microbiol 1993 31:2621 4.
18. Marchildon PA, Ciota LM, Zamaniyan FZ, et al. Evaluation of three commercial enzyme immunoassays compared with the 13C urea breath test for detection Helicobacter pylori infection. J Clin Microbiol 1996 34:1147 52.
19. Wilcox MH, Dent THS, Hunter JO, et al. Accuracy of serology for the diagnosis of Helicobacter pylori infection - a comparison of eight kits. J Clin Pathol 1996 49:373 6.
20. Raymond J, Sauvestre C, Kalach N, et al. Evaluation of a new serologic test for diagnosis of Helicobacter pylori infection in children. Eur J Clin Microbiol Infect Dis 1999 18:192 8.
21. Laheij RJ, Witteman EM, Bloembergen P, et al. Short-term follow-up by serology of patients given antibiotic treatment for Helicobacter pylori infection. J Clin Microbiol 1998 36:1193 6.
22. Kato S, Furuyama N, Ozawa K, et al. Long-term follow-up study of serum immunoglobulin G and immunoglobulin A antibodies after Helicobacter pylori eradication. Pediatrics 1999 104:1 5.
23. Cutler AF, Prasad VM. Long term follow-up of Helicobacter pylori serology after successful eradication. Am J Gastroenterol 1996 91:85 8.
24. Cutler AF, Prasad VM, Santogade P. Four-year trends in Helicobacter pylori IgG serology following successful eradication. Am J Med 1998 105:18 20.
25. Veenendaal RA, Pena AS, Meijer JL, et al. Long term serological surveillance after treatment of Helicobacter pylori infection. Gut 1991 32:1291 4.
26. Wang WM, Chen CY, Jan CM, et al. Long-term follow-up and serological study after triple therapy of Helicobacter pylori-associated duodenal ulcer. Am J Gastroenterol 1994 89:1793 6.
27. Glupczynski Y, Burette A, Goossens H, et al. Effect of antimicrobial therapy on the specific serological response to Helicobacter pylori infection. Eur J Clin Microbiol Infect Dis 1992 11:583 8.
28. Herbrink P, van Doorn LJ. Serological methods for diagnosis of Helicobacter pylori infection and monitoring eradication therapy. Eur J Clin Microbiol Infect Dis 2000 19:164 73.